After losing more than 4% in the last week of the year, Gold (XAU/USD) gathered bullish momentum as trading conditions ...

Estimated YUTREPIA net product sales of approximately $90.1 million in the fourth quarter and $148.3 million for full-year 2025Received more than 2,800 unique patient prescriptions since launch in Jun ...

The S&P/ASX 200 is set to trend higher today amid a rotation back into cyclical pockets of the market. Here are today's top ...

Gold (XAU/USD) remains under pressure on Thursday, with prices extending their pullback for a second consecutive day as ...

Learn how to create burndown charts to track project progress, improve team performance, and download free templates to get ...

If you are wondering whether Arm Holdings at around US$116 per share is priced fairly or not, you are not alone, many ...

If you are wondering whether CVS Health at around US$80.42 is offering fair value or a potential bargain, it helps to break ...

From the gold-versus-equities debate to the assumption that high growth guarantees high returns, a close look at long-term ...

The market underappreciates TENX's late-stage pipeline and risk-adjusted asset value; we recommend buying ahead of Phase 3 ...

Overnight strength in big tech failed to survive contact with US cash trading, leaving the market to grind forward without ...

Barclays upgraded Vertiv Holdings Co. to “overweight” from “equal weight” on Friday, citing higher earnings estimates and a revised valuation following recent share price volatility.

MarketSmith India reveals its top stock recommendations for today, 1 January. Get expert insights into the best-performing ...